Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-10

FDA Approved: MOTEGRITY — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for MOTEGRITY (prucalopride) from Takeda Pharmaceuticals America, Inc., indicating an update to the approved labelin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MOTEGRITY (Prucalopride)

Snippet

SUPPL AP for MOTEGRITY (PRUCALOPRIDE)